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Recent experimental advances have allowed the estimation of the in vivo rates of killing of infected target cells by cytotoxic T
lymphocytes (CTL). We present several refinements to a method applied previously to quantify killing of targets in the spleen
using a dynamical model. We reanalyse data previously used to estimate killing rates of CTL specific for two epitopes of
lymphocytic choriomeningitis virus (LCMV) in mice and show that, contrary to previous estimates the ‘‘killing rate’’ of effector
CTL is approximately twice that of memory CTL. Further, our method allows the fits to be visualized, and reveals one
potentially interesting discrepancy between fits and data. We discuss extensions to the basic CTL killing model to explain this
discrepancy and propose experimental tests to distinguish between them.
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INTRODUCTION
A detailed understanding of immune responses requires quanti-
fying the population dynamics of pathogens and immune cells. A
key element of these dynamics is the killing of infected cells by
cytotoxic T lymphocytes (CTL). We want to be able to
accurately measure how fast CTL can find and kill infected
target cells in vivo. This information will help answer many basic
immunological questions. For example, how do killing rates differ
between effector and memory CTL, and do these rates change as
CTL become exhausted in chronic infection? Answering these
questions will be particularly important for persistent infections
such as HIV.
Many studies have quantified cytotoxic T cell activity in vitro [1–
8]. More recently, mathematical models in conjuction with
advances in experimental techniques have allowed estimates of
CTL killing rates in vivo [9–14]. For a summary of the work in both
of these areas, we refer the reader to our review [15].
In this paper we present a refined analysis of a dataset
relating to CTL killing of LCMV-infected cells in a mouse
model, first presented by Barber et al. [16] and subsequently
analysed quantitatively by some of us [13]. Barchet et al. [17]
were among the first to use this simple but powerful assay.
Briefly, effector or memory CTL are generated by infecting
mice with LCMV and waiting either 8 or .30 days respectively.
To measure the rate of killing of target cells by CTL, a mixture
of fluorescently labelled cells containing equal proportions of
unpulsed controls and cells pulsed with either of the two
immunodominant LCMV epitopes (NP396 and GP276) is
injected intravenously into mice. To study effector and memory
CTL responses to these targets, the frequencies of CTL, control
cells and pulsed targets are measured in the spleen following
sacrifice of mice during the first few hours after injection of
targets (Figure 1).
To estimate killing rates from this assay, we need to take into
account two complications. First cells are flowing into the spleen
while killing is taking place. This results in some target cells being
under CTL surveillance for shorter durations than others. This
was addressed in [13] using a simple dynamical model of
migration and killing of target cells. They also took into account
a second problem, namely that different mice have different
numbers of splenocytes and spleen-resident CTL.
There are, however, further problems with this method, which
we address here. The most significant of these is the uncertainty
in the ‘take’ of injected cells (i.e. the number of injected cells that
end up in the spleen). This is variable for a combination of
reasons; different numbers of cells in each inoculum and
difficulties associated with targeting injections precisely into the
tail vein.
We show how this uncertainty can be removed from the
calculation by using the pairing of the estimates of unpulsed and
pulsed target cell frequencies in each animal. Importantly, this new
approach also allows clearer visualisation of the fits and the data.
Applying the method to the dataset first presented in [16] more
than doubles previous estimates of effector CTL killing rates.
Furthermore, the clearer visualization allowed by the new
approach reveals a systematic discrepancy between the data and
the model in one case. We propose several hypotheses to account
for this shortcoming of the current framework, and we describe
additional experiments that may allow us to discriminate between
these hypotheses.
METHODS
The basic model–the dynamics of target cells in
blood and spleen
We begin by describing the original method of estimation, and
then explain how it can be improved.
The flux of control or unpulsed cells from the blood to spleen
immediately following tail-vein injection is modelled as follows. If
N denotes the number of unpulsed cells in blood and U the
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_ N N(t)~   (szd)N(t) ð1Þ
_ U U(t)~sN(t) ð2Þ
or
Ut ðÞ ~
sN 0 ðÞ
szd
1 e{ szd ðÞ t
  
ð3Þ
where N(0) is the number of control cells injected into the blood at
the start of the experiment. We assume that the influx of pulsed
and unpulsed targets into the spleen is identical, but that in
addition pulsed targets are killed in the spleen. The total rate of
killing is assumed to take a mass-action form, proportional to the
product of the dimensionless frequencies of target cells and CTL in
the spleen. Assuming all mice have identical total splenocyte
numbers , then,
_ T Tt ðÞ ~
_ U Ut ðÞ
Ns
{kCT t ðÞ , ð4Þ
where T(t) and C are the frequencies of target cells and CTL in the
spleen, respectively. This equation assumes equal numbers of
pulsed and unpulsed target cells in the inoculum.
Ideally, all mice would be identical, with the same inoculum N(0),
spleen size Ns and CTL frequency C, and would differ only in the
time of sacrifice. If this were the case, we would estimate k as follows.
First fit the data for unpulsed target cells (Figure 1, green line) to
obtain the parameters governing the dynamics of unpulsed cells.
Then use these parameters to estimate k by fitting equation (4) to a
time series of measured target cell frequencies (Figure 1, red line).
Biological and Experimental Limitations
The above approach needs modification, because although we
would prefer all mice to be identical, in reality they differ
substantially in the following:
1. Spleen sizes (splenocyte numbers);
2. Number of CTL specific for GP and NP epitopes–this
depends on their response to the LCMV immunization;
3. The inocula for different mice contain slightly different
proportions of pulsed and unpulsed target cells.
We took these sources of variation into account in our original
study [13] by measuring Ns and C for each animal, as well as the
ratio of unpulsed to pulsed targets, f (measured separately for NP-
and GP-pulsed targets). Then for animal i sacrificed at time t,
_ T Ti t ðÞ ~fi
_ U Ut ðÞ
Ns ðÞ i
{kCiTi t ðÞ , ð5Þ
where k is the rate constant for killing, Ns is the total number of
splenocytes, U(t) is the total number of unpulsed targets in the
spleen and C is the frequency of CTL in the spleen (numbers/total
splenocytes) specific for the target cells of interest.
In our original approach we fitted the following equation to the
unpulsed cell data pooled from all animals at all timepoints to
obtain averaged estimates of c=sN(0) and d=s+d:
Ut ðÞ ~
sN 0 ðÞ
szd
1 e{ szd ðÞ t
  
~
c
d
1 e{dt   
: ð6Þ
This follows from equation (3). Using this in equation (5),
T
predicted
i t ðÞ ~fi
sN 0 ðÞ
Ns ðÞ i
e{ szd ðÞ t e{kCit
kCi{ szd ðÞ
  
: ð7Þ
Figure 1. The CTL killing assay. Peptide-pulsed target cells and control (unpulsed) cells are injected intravenously (A). The control cells allow us to
measure the flux of both populations into the spleen, and the differences between numbers of pulsed and unpulsed cells in the spleen at later
timepoints (panel B) is assumed to be due to killing by spleen-resident CTL.
doi:10.1371/journal.pone.0001301.g001
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measured target cell frequencies Ti(t) in the spleen by minimising
the quantity
X
i
logit T
predicted
i k ðÞ
  
{logit Tobserved
i
      2
:
The sum is over all animals i and the logit transform was used to
normalise the distributions of frequency measurements.
Improving the estimate of CTL killing rate k
The method above uses an averaged estimate for the unpulsed cell
numbers U(t) at each timepoint. This discards information,
however, since the data comprise paired measurements of Ti(t)
and Ui(t) for each animal. Using this paired information improves
the fitting procedure since a further source of variation is
removed–the initial ‘take’ of injected cells (i.e. the proportion of
the injected targets that migrate to the spleen, s/(s+d)) Since we
expect the uncertainty in the take to be identical for pulsed and
unpulsed targets in the same inoculum, the paired information can
be used to remove this uncertainty.
Substituting eqn. (6) into eqn. (7) gives
Ti t ðÞ ~fi
Ui t ðÞ
Ns ðÞ i
d
kCi{d
  
e{dt{e{kCit
1{e{dt
  
, ð8Þ
removing the unknown quantity c=sN(0) from the calculation,
and where d=s+d. Thus k can be estimated using the measured
values Ti, Ui,( Ns)i, fi and Ci together with the previous estimate of
d.
An alternative is to work with the proportion of the pulsed
targets in the spleen that have been killed, p(t)–
Proportion of targets killed~pi t ðÞ
~1{
Pulsed targets
Unpulsed targets
~1{
Ns ðÞ iTi t ðÞ
fiUi t ðÞ
~1{
d
kCi{d
  
e{dt{e{kCit
1{e{dt
  
,
ð9Þ
where unpulsed target cell numbers are multiplied by the ratio f to
correct for deviations from a 1:1 ratio of pulsed to unpulsed targets
in the inoculum. Working with the proportion of targets killed
makes visualising the raw data more straightforward, as we see
below.
In either case, a two-step process is used to estimate k:
1. First estimate the loss rate of injected cells from the blood,
d=s+d, using the unpulsed cell data alone. From eqn. (6), for
each animal i the total number of unpulsed target cells in the
spleen is
Ui t ðÞ ~Zi 1{e{dt   
where Zi is proportional to Ni(0). The parameter d can be
estimated with a non-linear least squares fit to the data from
all animals simultaneously and assuming Zi=Z is the same
(and unknown) for all animals.
2. Use this estimate of d to generate point estimates of kNP and
kGP using either equation (8) or (9).
Confidence intervals can be generated by repeating steps 1 and
2 on resampled datasets to generate empirical (bootstrap)
distributions of all three parameter estimates (d, kNP and kGP).
Transforming the data
Ideally the data should be transformed such that the errors are at
least approximately normally distributed, justifying a least-squares
fitting approach. Since the influx and loss of targets from the
spleen are modelled as exponential processes, an obvious approach
is to fit the logarithm of the target cell frequencies. However, these
frequencies are measured by FACS analysis and at late timepoints
when frequencies are low they are subject to increasing fractional
error. In particular, we do not expect the assumption of constant
error variance to hold on a logarithmic scale. For this reason we
argue that it is incorrect to fit to either the logarithm or the logit of
target cell frequencies (the logit function being approximately
equal to the logarithm for small arguments). A reasonable
alternative is to transform all cell frequency measurements using
the arcsine-square-root [18], and the results we present here are
generated using this data transformation. However, parameter
estimates do not differ substantially when we fit directly to the
untransformed cell frequencies or proportions.
Selecting an estimation method
Some of the uncertainty in k comes from variability in the injected
cell numbers N(0). We see from eqns (8) and (9) that N(0) does not
appear explicitly in the second step of our revised estimating
procedures. However, variation in N(0) generates uncertainty in
the estimate of d in the first step, which propagates into the second
step. To investigate whether this could introduce a bias in the
estimate of k, we took a Monte Carlo approach. First we analysed
the original data to estimate a distribution for the injected cell
numbers N(0), and then generated artificial datasets using this
distribution. We have
N 0 ðÞ ~
Ut ðÞ d
s 1{exp {dt ðÞ ðÞ
, ð10Þ
where U(t) is measured, and d and c=sN0 were previously
estimated Regoes, Barber, Ahmed, and Antia (d=0.021,
c=6.6610
3). We constrain estimates of s using the relations
0:0013~
c
NMAX
ƒ^ s sƒd~0:02,
where NMAX is the approximate number of cells in each injection
and so is an upper bound on the actual transferred number N(0).
We used a value s ˆ =0.01, and then estimated N(0) for each animal
using the observed values U(t) and eqn. (10). N(0) was well
described by a lognormal distribution with log(mean)=13.3 and
log(sd)=0.61. We then generated an artificial dataset by drawing a
value N(0)i from this distribution and a value of Ci from the
empirical distribution of CTL frequencies, and using these
numbers to generate U(ti) and T(ti) with eqns (6) and (7), using
the original estimate k=1.33 for NP targets killed by effector CTL.
Replicates were run to generate a cohort of simulated animals and
this dataset was used with the two-step estimation procedure to re-
estimate k. We show the results of fitting the model with both
methods in Table 1, as well as the results using the original method
[13].
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k=1.33 were all significant (t-test, p,0.001). On the basis of this
analysis we show fits to the proportion of targets killed, since it
provides our least biased estimator.
Note that eqn. (9) can easily be solved numerically to obtain
direct estimates of k for each animal. However, in this procedure
the parameters governing target cell influx (s and d) are taken to
be identical for each animal but the CTL killing rate k is assumed
to be variable, which we feel is an unreasonable assumption.
RESULTS
Revised estimates of killing rates with the basic
model
Compared to the original estimates, the killing rates of NP396 and
GP276-pulsed targets by effector CTL are both substantially
increased, while memory cell killing rates are comparable to the
originals. The raw data and fits are shown in Figure 2. Estimates of
k are summarized in Table 2 and Figure 3.
For all data, the estimates of k are essentially unchanged if we fit
directly to the untransformed rather than arcsin square-root
transformed proportions.
Discrepancies between the fits and data
This new approach allows clearer visualisation of the fits to the
data (Figure 2). In three of the four cases, the fits are reasonable as
assessed by the distribution of the residuals over time. However,
for GP-specific effector cells, the proportion of targets killed is
overestimated by the basic model at late timepoints; there is a
trend in the residuals over time, and the data appear to saturate at
less than 100% of targets. There are several potential explanations
for this.
1. Refractory targets A proportion q of the GP-pulsed cells
entering the spleen are susceptible to killing, and the remainder (1-
q) are effectively ‘‘invisible’’. With this modification to the model,
the proportion of targets killed is now simply
pt ðÞ ~q 1 
d
kC{d
  
e{dt{e{kCt
1{e{dt
     
: ð11Þ
This extended model for GP effectors improves the fit significantly
(p,10
23, F-test), provides an increased estimate of kGP of 5.32
(2.78, 8.50), and predicts that around 10% of GP targets are
effectively invisible to CTL in the spleen (q=0.87 (0.81, 0.92)).
There are at least two ways in which cells might be refractory.
They can be invisible to detection (either by presenting insufficient
peptide to be recognized by CTL, or by migrating to areas of the
spleen not accessible to CTL), or be resistant to killing. However,
these hypotheses are perhaps unlikely on the grounds that they
must be compatible with the remainder of the data. For example,
if there are areas of the spleen that are inaccessible to CTL, or a
proportion of targets are resistant to killing, then we expect a
similar proportion of targets to evade NP-specific effector CTL,
which is not observed (Figure 2, upper L panel). Also, since all
targets were pulsed with high doses of peptide, we do not expect
any targets to present peptide at levels below that required for
CTL recognition. However, this could be further tested by
injecting with targets pulsed with even larger amounts of peptide.
2. Epitope decay The GP epitopes are progressively lost from
target cells. In H-2b mice the GP276 epitope binds significantly
more weakly to MHC class I than NP396, with a 10-fold higher
dissociation rate [19]. If we assume that as a result of epitope
decay the GP effector killing rate kGP falls exponentially with time
as kGP=k0exp(2mt), we estimate k0=4.05 (3.02, 5.76) and m=7.72
(6.16, 9.36)610
23 min
21 for killing by GP-specific effector CTL.
This implies that the half life of the decay of k is around
90 minutes. This model is also unlikely, however, since while it
improves the fit for GP effector cells (p,10
28, F-test), it fails to
improve the fit for GP memory. Indeed, the loss of the GP276
epitope from target cells should have a greater impact on killing by
memory CTL, since net rates of killing are slower due to lower
CTL density. However, this model could be further tested by
incubating GP-pulsed targets prior to injection. GP killing rates
should then be further decreased.
3. CTL exhaustion When a CTL kills a target cell it is lost
from the pool of functional effector CTL and has to ‘recharge’. If
CTL are unable to recharge during the short time course of the
experiment, functional killers are then simply lost at rate equal to
the net rate of target cell loss, kCT. This model contains the same
parameters as the original and yields slightly increased estimates of
the GP killing rates, but does not reduce the residual sum of
squares significantly; kGP (effector)=2.30, DAIC=2.96; kGP
(memory)=1.03, DAIC=3.20. Despite this, the CTL exhaustion
model could be tested further by injecting a second (differently
labelled) cohort of pulsed and unpulsed targets soon after the first,
and determining whether the second cohort are killed more slowly
than the first.
DISCUSSION
Measuring CTL killing rates with this in vivo assay requires not
only modeling killing itself but also the flow of targets into the
spleen. We have improved our previous analysis by removing one
major source of uncertainty (variation in the number of targets
transferred intravenously) and using the natural pairing of
measurements to make fuller use of the information contained in
the data. In contrast to previous estimates we now predict that
effectors survey and kill approximately twice as rapidly as memory
cells. Further, in both effector and memory responses CTL specific
for the immunodominant NP396 epitope kill their targets
approximately twice as fast as CTL specific for the subdominant
GP276.
These estimates of CTL killing rates complement the informa-
tion gained from other methods, and in particular in two photon
intravital microscopy. Recent advances in this area allow the direct
visualization of killing in small regions of tissue or a lymph node
(e.g. [20,21]). This technique allowed the measurement of the
times spent in delivering the lethal hits to pulsed targets as well as
the time spent browsing pulsed and unpulsed targets. Unfortu-
nately the study by Mempel et al. [20] does not provide
information regarding the time unbound CTL take to locate
and attach to potential targets. This prevents direct comparisons
with our estimate of the rate k, which is the inverse of the mean
time to locate and survey targets. Mempel et al. also show that
Table 1. Using a Monte Carlo approach to examine bias in the
estimation methods.
......................................................................
Method k Std. error 95% CI
Original (Regoes et al.,PNAS 2007) 1.554 0.00720 (1.540, 1.568)
Direct fitting of target cell frequencies 1.354 0.00094 (1.353, 1.356)
Fitting the proportion of targets killed 1.332 0.00057 (1.331, 1.334)
Using 50000 simulated datasets each of 100 datapoints, we calculated the
mean, standard error and 95% confidence intervals for the estimated killing rate
k using the ‘true’ value k=1.33 and using the arcsine-square root
transformation.
doi:10.1371/journal.pone.0001301.t001
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k=0.72 (0.53, 0.92) k=1.57 (1.18, 1.96)
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is therefore possible that different levels of inhibition acting on
CTL specific for different LCMV epitopes could influence CTL
killing rates and that our estimates are not the ‘true’ killing rates of
these populations. Clearly, combining our assays with direct
visualization would be a powerful test allowing for the validation of
both methods.
Despite the improvements to our method we have described, a
small discrepancy between one of the four datasets and the fit (for
the GP effector data) suggests that the killing model could be
further refined. There are also other potential sources of error,
both in the assay and the models.
First, our estimate of k assumes that the ratio of pulsed to
unpulsed cells migrating into the spleen during the experiments is
identical to the ratio in the initial inoculum. This assumption
might be violated if there is differential sequestration of pulsed and
unpulsed targets cells in other tissues (such as the lungs). If cells
exposed to CTL in other organs in the body recirculate into the
blood, this will lead to enrichment of unpulsed targets in the blood
and overestimation of killing rates in the spleen. Conversely, if
recirculation of cells exposed to CTL can be neglected, our
estimate of the killing in the spleen is unaffected. The importance
of extra-splenic killing and recirculation could be tested with non-
destructive sampling of the blood immediately after transfer (that
is, over the short timescale during which cells are migrating into
the spleen) to test that the ratio of pulsed to unpulsed targets in
blood is preserved.
A second potential problem is the assumption that killing can be
described by a mass-action term. Our models assume a killing rate
of kCT where C and T are the CTL and target cell frequencies in
the spleen, respectively. This is expected to hold for well-mixed
populations at intermediate C:T ratios. When the C:T ratio is very
low (=1) the net rate of killing is limited not only by the encounter
rate of CTL and targets, as assumed by mass-action, but also by
CTL recycling and/or the ‘dwell time’ taken for a single CTL to
browse a potential target cell, deliver the cytolytic granules and
detach from it. At high CTL densities and high C:T ratios,
multiple CTL may bind to a single target and so mass-action may
also break down. For GP memory cells the mean C:T (or
‘effector:target’) ratio over all timepoints was 1.46 (1.09, 2.08) and
for NP memory it was 4.92 (3.43, 7.46), and so we might expect
mass action to hold. For effectors, C:T was 917 (1350, 3040) for
NP and 129 (87, 193) for GP. Particularly for the effector
populations, then, estimates of k might be improved further by
introducing the possibility of pulsed targets being hit by multiple
CTL.
A third potential issue is that we identified specific CTL using
tetramer staining only. It is possible that only a proportion of these
cells express effector molecules such as perforin and granzyme and
are capable of killing. Clearly, overestimating the number of
functional CTL will underestimate killing rates. However, the
relationship between killing in vivo and the expression levels of
these molecules has not been definitively established. For example,
exhausted CTL express significantly higher levels of Granzyme B
than memory cells [22] and yet are unable to kill, and CTL can kill
without perforin [23]. The method we propose smoothes over any
heterogeneity in the epitope-specific CTL response and provides
an average efficiency of killing for each specificity.
Finally, we note an important difference between our approach
and those used in quantitative studies of cell lysis or virus
dynamics. For example, in HIV infection, the analysis of the decay
of circulating virus in the blood directly after treatment with anti-
viral drugs allows the extraction of important biological param-
eters such as infected cell lifetime and the half life of free virus [24].
r
Figure 2. The fits (square panels) of the basic killing model to the data using the proportion of GP and NP-pulsed target cells that are killed over
time, by effector CTL (upper panels) and memory CTL (lower panels) in the spleen. In the square panels the black open circles show the measured
proportion of targets killed, and the fitted values for each animal are shown offset to the right in red open circles. The residuals after arcsin square-
root transformation are shown below each fit in the rectangular panels. Best fit estimates of k in units of min
21 are shown in each panel, with 95%
confidence intervals.
doi:10.1371/journal.pone.0001301.g002
Table 2. Original and revised estimates of killing rates, using
paired estimates of pulsed and unpulsed targets.
......................................................................
Original Revised
Effector kNP 1.33 (0.70,2.15) 3.71 (2.76,4.84)
kGP 0.70 (0.50,0.97) 2.19 (1.47,3.77)
Memory kNP 1.45 (0.92,2.33) 1.57 (1.18,1.96)
kGP 0.99 (0.43,1.77) 0.72 (0.53,0.92)
Confidence intervals are shown in parentheses and were calculated using the
adjusted percentile method with 1000 (original results) or 2000 (revised
estimates) bootstrap replicates.
doi:10.1371/journal.pone.0001301.t002
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Figure 3. Estimates of the killing rate with 95% confidence intervals
using the original procedure [13] and the revised method. This
represents the data presented in Table 2.
doi:10.1371/journal.pone.0001301.g003
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PLoS ONE | www.plosone.org 6 December 2007 | Issue 12 | e1301With the assay and models we discuss here, pulsed/unpulsed
target cell numbers in the spleen should asymptotically approach
exponential decay with half life ln(2)/(kC) once influx is complete.
However, by this stage target cell numbers are small and difficult
to measure accurately, and measurements may be further
complicated by efflux from the spleen. For these reasons,
maximum information for the estimation of k perhaps comes
from early or intermediate timepoints when both influx and killing
must be considered.
Our work stresses how a close collaborations between
experimental and theoretical immunologists is vital in order to
measure important quantities such as how fast CTL can find and
kill target cells.
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